nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.299	0.346	CbGbCtD
Valsartan—SLCO1B3—Methotrexate—ankylosing spondylitis	0.206	0.238	CbGbCtD
Valsartan—ALB—Prednisone—ankylosing spondylitis	0.131	0.151	CbGbCtD
Valsartan—SLCO1B1—Methotrexate—ankylosing spondylitis	0.12	0.139	CbGbCtD
Valsartan—ALB—Methotrexate—ankylosing spondylitis	0.0656	0.0759	CbGbCtD
Valsartan—CYP2C9—Dexamethasone—ankylosing spondylitis	0.044	0.0509	CbGbCtD
Valsartan—Angioedema—Prednisolone—ankylosing spondylitis	0.000517	0.00383	CcSEcCtD
Valsartan—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00051	0.00377	CcSEcCtD
Valsartan—Vertigo—Prednisolone—ankylosing spondylitis	0.000509	0.00376	CcSEcCtD
Valsartan—Syncope—Prednisolone—ankylosing spondylitis	0.000508	0.00376	CcSEcCtD
Valsartan—Back pain—Triamcinolone—ankylosing spondylitis	0.000504	0.00373	CcSEcCtD
Valsartan—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000498	0.00368	CcSEcCtD
Valsartan—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000492	0.00364	CcSEcCtD
Valsartan—Angiopathy—Betamethasone—ankylosing spondylitis	0.000492	0.00364	CcSEcCtD
Valsartan—Alopecia—Betamethasone—ankylosing spondylitis	0.00048	0.00355	CcSEcCtD
Valsartan—Alopecia—Dexamethasone—ankylosing spondylitis	0.00048	0.00355	CcSEcCtD
Valsartan—Angioedema—Triamcinolone—ankylosing spondylitis	0.000476	0.00352	CcSEcCtD
Valsartan—Haemoglobin—Prednisone—ankylosing spondylitis	0.000475	0.00351	CcSEcCtD
Valsartan—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000475	0.00351	CcSEcCtD
Valsartan—Haemorrhage—Prednisone—ankylosing spondylitis	0.000473	0.0035	CcSEcCtD
Valsartan—Vertigo—Triamcinolone—ankylosing spondylitis	0.000468	0.00346	CcSEcCtD
Valsartan—Syncope—Triamcinolone—ankylosing spondylitis	0.000467	0.00345	CcSEcCtD
Valsartan—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000467	0.00345	CcSEcCtD
Valsartan—Syncope—Methylprednisolone—ankylosing spondylitis	0.000466	0.00345	CcSEcCtD
Valsartan—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000464	0.00344	CcSEcCtD
Valsartan—Oedema—Prednisolone—ankylosing spondylitis	0.000462	0.00342	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000462	0.00342	CcSEcCtD
Valsartan—Neutropenia—Methotrexate—ankylosing spondylitis	0.000461	0.00341	CcSEcCtD
Valsartan—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000459	0.00339	CcSEcCtD
Valsartan—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000458	0.00338	CcSEcCtD
Valsartan—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000457	0.00338	CcSEcCtD
Valsartan—Shock—Prednisolone—ankylosing spondylitis	0.000455	0.00336	CcSEcCtD
Valsartan—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000455	0.00336	CcSEcCtD
Valsartan—Cough—Triamcinolone—ankylosing spondylitis	0.000454	0.00336	CcSEcCtD
Valsartan—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00045	0.00333	CcSEcCtD
Valsartan—Myalgia—Triamcinolone—ankylosing spondylitis	0.000443	0.00328	CcSEcCtD
Valsartan—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000442	0.00327	CcSEcCtD
Valsartan—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000442	0.00327	CcSEcCtD
Valsartan—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000441	0.00326	CcSEcCtD
Valsartan—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00044	0.00325	CcSEcCtD
Valsartan—Infestation—Methotrexate—ankylosing spondylitis	0.00044	0.00325	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000439	0.00325	CcSEcCtD
Valsartan—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000434	0.00321	CcSEcCtD
Valsartan—Renal failure—Methotrexate—ankylosing spondylitis	0.000433	0.0032	CcSEcCtD
Valsartan—Angioedema—Betamethasone—ankylosing spondylitis	0.000432	0.00319	CcSEcCtD
Valsartan—Angioedema—Dexamethasone—ankylosing spondylitis	0.000432	0.00319	CcSEcCtD
Valsartan—Angiopathy—Prednisone—ankylosing spondylitis	0.000429	0.00317	CcSEcCtD
Valsartan—Immune system disorder—Prednisone—ankylosing spondylitis	0.000427	0.00316	CcSEcCtD
Valsartan—Oedema—Triamcinolone—ankylosing spondylitis	0.000425	0.00314	CcSEcCtD
Valsartan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000425	0.00314	CcSEcCtD
Valsartan—Vertigo—Betamethasone—ankylosing spondylitis	0.000424	0.00314	CcSEcCtD
Valsartan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000424	0.00314	CcSEcCtD
Valsartan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000424	0.00314	CcSEcCtD
Valsartan—Syncope—Dexamethasone—ankylosing spondylitis	0.000424	0.00313	CcSEcCtD
Valsartan—Syncope—Betamethasone—ankylosing spondylitis	0.000424	0.00313	CcSEcCtD
Valsartan—Infection—Triamcinolone—ankylosing spondylitis	0.000422	0.00312	CcSEcCtD
Valsartan—Infection—Methylprednisolone—ankylosing spondylitis	0.000421	0.00312	CcSEcCtD
Valsartan—Shock—Triamcinolone—ankylosing spondylitis	0.000418	0.00309	CcSEcCtD
Valsartan—Insomnia—Prednisolone—ankylosing spondylitis	0.000418	0.00309	CcSEcCtD
Valsartan—Alopecia—Prednisone—ankylosing spondylitis	0.000418	0.00309	CcSEcCtD
Valsartan—Shock—Methylprednisolone—ankylosing spondylitis	0.000417	0.00309	CcSEcCtD
Valsartan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000416	0.00308	CcSEcCtD
Valsartan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000415	0.00307	CcSEcCtD
Valsartan—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000415	0.00307	CcSEcCtD
Valsartan—Epistaxis—Methotrexate—ankylosing spondylitis	0.000415	0.00307	CcSEcCtD
Valsartan—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000415	0.00307	CcSEcCtD
Valsartan—Mental disorder—Prednisone—ankylosing spondylitis	0.000414	0.00306	CcSEcCtD
Valsartan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000412	0.00305	CcSEcCtD
Valsartan—Malnutrition—Prednisone—ankylosing spondylitis	0.000411	0.00304	CcSEcCtD
Valsartan—Myalgia—Dexamethasone—ankylosing spondylitis	0.000402	0.00297	CcSEcCtD
Valsartan—Myalgia—Betamethasone—ankylosing spondylitis	0.000402	0.00297	CcSEcCtD
Valsartan—Anxiety—Dexamethasone—ankylosing spondylitis	0.000401	0.00296	CcSEcCtD
Valsartan—Anxiety—Betamethasone—ankylosing spondylitis	0.000401	0.00296	CcSEcCtD
Valsartan—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000397	0.00294	CcSEcCtD
Valsartan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000396	0.00293	CcSEcCtD
Valsartan—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000395	0.00292	CcSEcCtD
Valsartan—Hepatitis—Methotrexate—ankylosing spondylitis	0.000395	0.00292	CcSEcCtD
Valsartan—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000392	0.0029	CcSEcCtD
Valsartan—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00039	0.00289	CcSEcCtD
Valsartan—Vision blurred—Prednisone—ankylosing spondylitis	0.000388	0.00287	CcSEcCtD
Valsartan—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000387	0.00286	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000387	0.00286	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000386	0.00286	CcSEcCtD
Valsartan—Oedema—Betamethasone—ankylosing spondylitis	0.000386	0.00285	CcSEcCtD
Valsartan—Oedema—Dexamethasone—ankylosing spondylitis	0.000386	0.00285	CcSEcCtD
Valsartan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000386	0.00285	CcSEcCtD
Valsartan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000386	0.00285	CcSEcCtD
Valsartan—Insomnia—Triamcinolone—ankylosing spondylitis	0.000384	0.00284	CcSEcCtD
Valsartan—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000384	0.00284	CcSEcCtD
Valsartan—Infection—Betamethasone—ankylosing spondylitis	0.000383	0.00283	CcSEcCtD
Valsartan—Infection—Dexamethasone—ankylosing spondylitis	0.000383	0.00283	CcSEcCtD
Valsartan—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000382	0.00282	CcSEcCtD
Valsartan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000381	0.00282	CcSEcCtD
Valsartan—Shock—Betamethasone—ankylosing spondylitis	0.000379	0.00281	CcSEcCtD
Valsartan—Shock—Dexamethasone—ankylosing spondylitis	0.000379	0.00281	CcSEcCtD
Valsartan—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000379	0.0028	CcSEcCtD
Valsartan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000378	0.0028	CcSEcCtD
Valsartan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000378	0.0028	CcSEcCtD
Valsartan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000378	0.00279	CcSEcCtD
Valsartan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000378	0.00279	CcSEcCtD
Valsartan—Angioedema—Prednisone—ankylosing spondylitis	0.000376	0.00278	CcSEcCtD
Valsartan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000374	0.00277	CcSEcCtD
Valsartan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000373	0.00276	CcSEcCtD
Valsartan—Vertigo—Prednisone—ankylosing spondylitis	0.00037	0.00273	CcSEcCtD
Valsartan—Syncope—Prednisone—ankylosing spondylitis	0.000369	0.00273	CcSEcCtD
Valsartan—Anorexia—Betamethasone—ankylosing spondylitis	0.000368	0.00272	CcSEcCtD
Valsartan—Anorexia—Dexamethasone—ankylosing spondylitis	0.000368	0.00272	CcSEcCtD
Valsartan—Urticaria—Prednisolone—ankylosing spondylitis	0.000367	0.00272	CcSEcCtD
Valsartan—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000367	0.00271	CcSEcCtD
Valsartan—Fatigue—Triamcinolone—ankylosing spondylitis	0.000366	0.00271	CcSEcCtD
Valsartan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000366	0.0027	CcSEcCtD
Valsartan—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000362	0.00267	CcSEcCtD
Valsartan—Hypotension—Dexamethasone—ankylosing spondylitis	0.00036	0.00266	CcSEcCtD
Valsartan—Hypotension—Betamethasone—ankylosing spondylitis	0.00036	0.00266	CcSEcCtD
Valsartan—Angiopathy—Methotrexate—ankylosing spondylitis	0.000358	0.00265	CcSEcCtD
Valsartan—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000357	0.00264	CcSEcCtD
Valsartan—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000356	0.00263	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000351	0.0026	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000351	0.0026	CcSEcCtD
Valsartan—Myalgia—Prednisone—ankylosing spondylitis	0.00035	0.00259	CcSEcCtD
Valsartan—Arthralgia—Prednisone—ankylosing spondylitis	0.00035	0.00259	CcSEcCtD
Valsartan—Anxiety—Prednisone—ankylosing spondylitis	0.000349	0.00258	CcSEcCtD
Valsartan—Alopecia—Methotrexate—ankylosing spondylitis	0.000349	0.00258	CcSEcCtD
Valsartan—Insomnia—Dexamethasone—ankylosing spondylitis	0.000349	0.00258	CcSEcCtD
Valsartan—Insomnia—Betamethasone—ankylosing spondylitis	0.000349	0.00258	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000348	0.00257	CcSEcCtD
Valsartan—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000347	0.00256	CcSEcCtD
Valsartan—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000346	0.00256	CcSEcCtD
Valsartan—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000346	0.00256	CcSEcCtD
Valsartan—Mental disorder—Methotrexate—ankylosing spondylitis	0.000346	0.00256	CcSEcCtD
Valsartan—Malnutrition—Methotrexate—ankylosing spondylitis	0.000344	0.00254	CcSEcCtD
Valsartan—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00034	0.00252	CcSEcCtD
Valsartan—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000339	0.00251	CcSEcCtD
Valsartan—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000339	0.00251	CcSEcCtD
Valsartan—Urticaria—Triamcinolone—ankylosing spondylitis	0.000338	0.0025	CcSEcCtD
Valsartan—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000337	0.00249	CcSEcCtD
Valsartan—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000337	0.00249	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000336	0.00248	CcSEcCtD
Valsartan—Oedema—Prednisone—ankylosing spondylitis	0.000336	0.00248	CcSEcCtD
Valsartan—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000335	0.00248	CcSEcCtD
Valsartan—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000335	0.00248	CcSEcCtD
Valsartan—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000335	0.00248	CcSEcCtD
Valsartan—Infection—Prednisone—ankylosing spondylitis	0.000334	0.00247	CcSEcCtD
Valsartan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000333	0.00246	CcSEcCtD
Valsartan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000333	0.00246	CcSEcCtD
Valsartan—Back pain—Methotrexate—ankylosing spondylitis	0.000333	0.00246	CcSEcCtD
Valsartan—Fatigue—Betamethasone—ankylosing spondylitis	0.000332	0.00246	CcSEcCtD
Valsartan—Fatigue—Dexamethasone—ankylosing spondylitis	0.000332	0.00246	CcSEcCtD
Valsartan—Shock—Prednisone—ankylosing spondylitis	0.00033	0.00244	CcSEcCtD
Valsartan—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000329	0.00244	CcSEcCtD
Valsartan—Skin disorder—Prednisone—ankylosing spondylitis	0.000326	0.00241	CcSEcCtD
Valsartan—Vision blurred—Methotrexate—ankylosing spondylitis	0.000324	0.0024	CcSEcCtD
Valsartan—Anorexia—Prednisone—ankylosing spondylitis	0.00032	0.00237	CcSEcCtD
Valsartan—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000315	0.00233	CcSEcCtD
Valsartan—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000315	0.00233	CcSEcCtD
Valsartan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000313	0.00232	CcSEcCtD
Valsartan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000312	0.00231	CcSEcCtD
Valsartan—Vertigo—Methotrexate—ankylosing spondylitis	0.000309	0.00228	CcSEcCtD
Valsartan—Urticaria—Betamethasone—ankylosing spondylitis	0.000306	0.00227	CcSEcCtD
Valsartan—Urticaria—Dexamethasone—ankylosing spondylitis	0.000306	0.00227	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000306	0.00226	CcSEcCtD
Valsartan—Dizziness—Prednisolone—ankylosing spondylitis	0.000306	0.00226	CcSEcCtD
Valsartan—Asthenia—Triamcinolone—ankylosing spondylitis	0.000305	0.00226	CcSEcCtD
Valsartan—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000305	0.00225	CcSEcCtD
Valsartan—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000305	0.00225	CcSEcCtD
Valsartan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000304	0.00225	CcSEcCtD
Valsartan—Insomnia—Prednisone—ankylosing spondylitis	0.000304	0.00225	CcSEcCtD
Valsartan—Paraesthesia—Prednisone—ankylosing spondylitis	0.000302	0.00223	CcSEcCtD
Valsartan—Pruritus—Triamcinolone—ankylosing spondylitis	0.000301	0.00222	CcSEcCtD
Valsartan—Cough—Methotrexate—ankylosing spondylitis	0.0003	0.00222	CcSEcCtD
Valsartan—Pruritus—Methylprednisolone—ankylosing spondylitis	0.0003	0.00222	CcSEcCtD
Valsartan—Dyspepsia—Prednisone—ankylosing spondylitis	0.000296	0.00219	CcSEcCtD
Valsartan—Myalgia—Methotrexate—ankylosing spondylitis	0.000293	0.00217	CcSEcCtD
Valsartan—Chest pain—Methotrexate—ankylosing spondylitis	0.000293	0.00217	CcSEcCtD
Valsartan—Arthralgia—Methotrexate—ankylosing spondylitis	0.000293	0.00217	CcSEcCtD
Valsartan—Decreased appetite—Prednisone—ankylosing spondylitis	0.000292	0.00216	CcSEcCtD
Valsartan—Rash—Prednisolone—ankylosing spondylitis	0.000291	0.00215	CcSEcCtD
Valsartan—Dermatitis—Prednisolone—ankylosing spondylitis	0.000291	0.00215	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000291	0.00215	CcSEcCtD
Valsartan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00029	0.00215	CcSEcCtD
Valsartan—Fatigue—Prednisone—ankylosing spondylitis	0.00029	0.00214	CcSEcCtD
Valsartan—Headache—Prednisolone—ankylosing spondylitis	0.00029	0.00214	CcSEcCtD
Valsartan—Constipation—Prednisone—ankylosing spondylitis	0.000287	0.00212	CcSEcCtD
Valsartan—Dizziness—Triamcinolone—ankylosing spondylitis	0.000281	0.00208	CcSEcCtD
Valsartan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000281	0.00208	CcSEcCtD
Valsartan—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00028	0.00207	CcSEcCtD
Valsartan—Infection—Methotrexate—ankylosing spondylitis	0.000279	0.00206	CcSEcCtD
Valsartan—Asthenia—Betamethasone—ankylosing spondylitis	0.000277	0.00205	CcSEcCtD
Valsartan—Asthenia—Dexamethasone—ankylosing spondylitis	0.000277	0.00205	CcSEcCtD
Valsartan—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000275	0.00204	CcSEcCtD
Valsartan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000275	0.00203	CcSEcCtD
Valsartan—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000275	0.00203	CcSEcCtD
Valsartan—Nausea—Prednisolone—ankylosing spondylitis	0.000274	0.00203	CcSEcCtD
Valsartan—Pruritus—Dexamethasone—ankylosing spondylitis	0.000273	0.00202	CcSEcCtD
Valsartan—Pruritus—Betamethasone—ankylosing spondylitis	0.000273	0.00202	CcSEcCtD
Valsartan—Skin disorder—Methotrexate—ankylosing spondylitis	0.000273	0.00202	CcSEcCtD
Valsartan—Vomiting—Triamcinolone—ankylosing spondylitis	0.00027	0.002	CcSEcCtD
Valsartan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00027	0.00199	CcSEcCtD
Valsartan—Rash—Triamcinolone—ankylosing spondylitis	0.000268	0.00198	CcSEcCtD
Valsartan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000268	0.00198	CcSEcCtD
Valsartan—Anorexia—Methotrexate—ankylosing spondylitis	0.000268	0.00198	CcSEcCtD
Valsartan—Rash—Methylprednisolone—ankylosing spondylitis	0.000267	0.00198	CcSEcCtD
Valsartan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000267	0.00198	CcSEcCtD
Valsartan—Urticaria—Prednisone—ankylosing spondylitis	0.000267	0.00197	CcSEcCtD
Valsartan—Headache—Triamcinolone—ankylosing spondylitis	0.000266	0.00197	CcSEcCtD
Valsartan—Headache—Methylprednisolone—ankylosing spondylitis	0.000266	0.00196	CcSEcCtD
Valsartan—Abdominal pain—Prednisone—ankylosing spondylitis	0.000265	0.00196	CcSEcCtD
Valsartan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000264	0.00195	CcSEcCtD
Valsartan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000264	0.00195	CcSEcCtD
Valsartan—Hypotension—Methotrexate—ankylosing spondylitis	0.000262	0.00194	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000256	0.00189	CcSEcCtD
Valsartan—Dizziness—Dexamethasone—ankylosing spondylitis	0.000255	0.00189	CcSEcCtD
Valsartan—Dizziness—Betamethasone—ankylosing spondylitis	0.000255	0.00189	CcSEcCtD
Valsartan—Insomnia—Methotrexate—ankylosing spondylitis	0.000254	0.00188	CcSEcCtD
Valsartan—Nausea—Triamcinolone—ankylosing spondylitis	0.000252	0.00187	CcSEcCtD
Valsartan—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000252	0.00186	CcSEcCtD
Valsartan—Nausea—Methylprednisolone—ankylosing spondylitis	0.000252	0.00186	CcSEcCtD
Valsartan—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00025	0.00185	CcSEcCtD
Valsartan—Somnolence—Methotrexate—ankylosing spondylitis	0.000249	0.00185	CcSEcCtD
Valsartan—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000247	0.00183	CcSEcCtD
Valsartan—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000247	0.00183	CcSEcCtD
Valsartan—Vomiting—Betamethasone—ankylosing spondylitis	0.000245	0.00181	CcSEcCtD
Valsartan—Vomiting—Dexamethasone—ankylosing spondylitis	0.000245	0.00181	CcSEcCtD
Valsartan—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000244	0.0018	CcSEcCtD
Valsartan—Rash—Betamethasone—ankylosing spondylitis	0.000243	0.0018	CcSEcCtD
Valsartan—Rash—Dexamethasone—ankylosing spondylitis	0.000243	0.0018	CcSEcCtD
Valsartan—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000243	0.0018	CcSEcCtD
Valsartan—Dermatitis—Betamethasone—ankylosing spondylitis	0.000243	0.0018	CcSEcCtD
Valsartan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000242	0.00179	CcSEcCtD
Valsartan—Fatigue—Methotrexate—ankylosing spondylitis	0.000242	0.00179	CcSEcCtD
Valsartan—Headache—Dexamethasone—ankylosing spondylitis	0.000242	0.00179	CcSEcCtD
Valsartan—Headache—Betamethasone—ankylosing spondylitis	0.000242	0.00179	CcSEcCtD
Valsartan—Asthenia—Prednisone—ankylosing spondylitis	0.000241	0.00178	CcSEcCtD
Valsartan—Pruritus—Prednisone—ankylosing spondylitis	0.000238	0.00176	CcSEcCtD
Valsartan—Diarrhoea—Prednisone—ankylosing spondylitis	0.00023	0.0017	CcSEcCtD
Valsartan—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000229	0.0017	CcSEcCtD
Valsartan—Nausea—Betamethasone—ankylosing spondylitis	0.000229	0.00169	CcSEcCtD
Valsartan—Nausea—Dexamethasone—ankylosing spondylitis	0.000229	0.00169	CcSEcCtD
Valsartan—Urticaria—Methotrexate—ankylosing spondylitis	0.000223	0.00165	CcSEcCtD
Valsartan—Dizziness—Prednisone—ankylosing spondylitis	0.000222	0.00164	CcSEcCtD
Valsartan—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000222	0.00164	CcSEcCtD
Valsartan—Vomiting—Prednisone—ankylosing spondylitis	0.000214	0.00158	CcSEcCtD
Valsartan—Rash—Prednisone—ankylosing spondylitis	0.000212	0.00157	CcSEcCtD
Valsartan—Dermatitis—Prednisone—ankylosing spondylitis	0.000212	0.00156	CcSEcCtD
Valsartan—Headache—Prednisone—ankylosing spondylitis	0.00021	0.00156	CcSEcCtD
Valsartan—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000207	0.00153	CcSEcCtD
Valsartan—Asthenia—Methotrexate—ankylosing spondylitis	0.000201	0.00149	CcSEcCtD
Valsartan—Nausea—Prednisone—ankylosing spondylitis	0.000199	0.00148	CcSEcCtD
Valsartan—Pruritus—Methotrexate—ankylosing spondylitis	0.000199	0.00147	CcSEcCtD
Valsartan—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000192	0.00142	CcSEcCtD
Valsartan—Dizziness—Methotrexate—ankylosing spondylitis	0.000186	0.00137	CcSEcCtD
Valsartan—Vomiting—Methotrexate—ankylosing spondylitis	0.000178	0.00132	CcSEcCtD
Valsartan—Rash—Methotrexate—ankylosing spondylitis	0.000177	0.00131	CcSEcCtD
Valsartan—Dermatitis—Methotrexate—ankylosing spondylitis	0.000177	0.00131	CcSEcCtD
Valsartan—Headache—Methotrexate—ankylosing spondylitis	0.000176	0.0013	CcSEcCtD
Valsartan—Nausea—Methotrexate—ankylosing spondylitis	0.000167	0.00123	CcSEcCtD
